Koyfin Home > Directory > Health Care > Illumina Inc > EBITDA / Interest Expenses

Illumina Inc EBITDA / Interest Expenses Chart (ILMN)

Illumina Inc annual/quarterly EBITDA / Interest Expenses from 2006 to 2018. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Illumina Inc EBITDA / Interest Expenses for the quarter ending September 09, 2018 was $19m a -30.17% decrease of -6m year over year
  • Illumina Inc EBITDA / Interest Expenses for the last 12 months ending September 09, 2018 was $29m a 26.87% increase of 8m year over year
  • Illumina Inc Annual EBITDA / Interest Expenses for 2017 was $21m a -2.68% decrease of -1m from 2016
  • Illumina Inc Annual EBITDA / Interest Expenses for 2017 was $22m a 19.51% increase of 4m from 2016
  • Illumina Inc Annual EBITDA / Interest Expenses for 2016 was $18m a 17.24% increase of 3m from 2015
Other Ratios Metrics:
  • Illumina Inc Total Debt / Capital for the quarter ending December 12, 2018 was $34m a 14.87% increase of 5m year over year
  • Illumina Inc Other Liabilities for the quarter ending December 12, 2018 was $359m a -1.39% decrease of -5m year over year
  • Illumina Inc Total Debt / Equity for the quarter ending December 12, 2018 was $51m a 20.88% increase of 11m year over year
View Chart On Koyfin

Quarterly ILMN EBITDA / Interest Expenses Data

09/2018$19m
07/2018$25m
04/2018$23m
12/2017$25m
10/2017$22m
07/2017$22m
04/2017$14m
01/2017$23m
10/2016$22m
07/2016$23m

Annual ILMN EBITDA / Interest Expenses Data

2017$21m
2017$22m
2016$18m
2014$14m
2013$9m
2012$9m
2012$9m
2011$10m
2010$7m
2008$6m